Answers are grounded in this paper and cite their sources.
Neuroendoscopy-compatible catheter enhances drug delivery and reduces risks in hypothalamic DBS, indicating promising therapeutic potential.
As hypothalamic deep brain stimulation (DBS) has been clinically proven effective for treating various neurological conditions, there is a growing need for strategies that minimize invasiveness while maximizing therapeutic efficacy. We propose a highly translational multifunctional neurostimulation catheter compatible with endoscopic access to the third ventricule for targeted ventromedial hypothalamic deep brain stimulation. This approach offers several key advantages: (1) a multifunctional catheter for both electrical and pharmaceutical intervention, (2) a minimally-invasive implantation procedure, and (3) enhanced electrode contacts with the third ventricle wall to access the underlying hypothalamic nuclei. The system comprises a flexible catheter with integrated thin-film microelectrodes, a customized cylindrical connector, extension wires, and a customized neurostimulator. The design features its high compatibility with clinically available neurosurgical tools, including guide wires and burr hole valves. We evaluated electrochemical performance under various bending conditions and assessed the safety and long-term device reliability. In addition, we demonstrated successful implantation into a Polydimethylsiloxane (PDMS) mold shaped to sit in the third ventricle, simulated the electric potential distribution using finite element analysis, and validated a clinically compatible drug delivery procedure. This novel implantation strategy holds promise for reducing procedural risks associated with hypothalamic deep brain stimulation.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: